Dahua Technology Unveils Full-color Cube to Explore New Possibilities of Innovation
19.4.2023 15:45:00 EEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric AIoT solution and service provider, unveils the 2023 Full-color Cube concept —— a cube of color magic that combines Full-color, Smart Dual Light and other technologies into infinite possibilities of innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230419005078/en/
For years, Dahua has been investing in Full-color Technology that assures users 24/7 colorful monitoring as well as trust-worthy performance in terms of clarity, definition, flexibility, accuracy and intelligence. This year, meet Full-color Cube! It integrates Full-color and Smart Dual Light with other technologies, creating infinite possibilities for innovation and allowing you to do more than you could ever imagine. (Photo: Business Wire)
“Dahua’s Full-color technology is continuously being upgraded, with the addition of Smart Dual Light as one great example. This year, we combined these two core technologies with AI, Duo and PT cameras, as well as other technologies to offer the Full-color Cube that further addresses users’ monitoring needs for vivid and color images in low-light environments,” said Eaden Xie, Product Manager at Dahua Technology.
Featuring panoramic vision, more personalized and flexible settings, intelligence at will, and future growth, the Full-color Cube unlocks a wealth of cutting-edge security functions through strong technological combinations.
Full-color + Panoramic: seamless 180° wide-angle image
The Full-color Panoramic series achieves a wider range of vision coverage by utilizing the capabilities of both Full-color Duo and PT cameras.
- Full-color + Duo
Based on Dahua’s advanced pixel-level metadata fusion algorithm, Full-color Duo camera adopts Dual F1.0 Aperture Lens and Dual 1/1.8" CMOS Sensors to create better imaging effects in low-light conditions. Compared with traditional cameras, its seamless 180° image significantly saves equipment and installation costs. Also, the eyeball model supports 3-axis rotation, which makes installation and operation more convenient. Moreover, its EPTZ function features panoramic image with multiple target details.
- Full-color + PT
Equipped with larger pan & tilt angle, Full-color PT camera provides an expanded field of view with fewer blind spots, while capturing 24/7 color images for more information and details. A variety of mounting brackets makes it easy to install on a pole, ceiling, or wall.
TiOC: full-time protection before, during, and after an event
TiOC (Three-in-One Camera) is a star product of the Dahua Full-color family that integrates Smart Dual Light, Active Deterrence, and AI. Before the event, SMD 4.0 and Perimeter Protection technology accurately focuses on human and vehicle alarms. During the event, Smart Dual Light technology records events in color, while actively deterring intruders with red and blue lights and siren. After the event, Smart Search quickly retrieves target footages, reducing investigation time. TiOC also allows third-party platform access for live broadcast/playback, video and audio parameter configuration, etc.
For more details about Full-color Cubes, please visit here .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230419005078/en/
Contact information
Zoe Xu (xu_shuyi@dahuatech.com )
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom